The TGF-β signaling pathway exhibits pleiotropic behavior, functioning as a tumor-suppressor in normal cells but transitioning to a tumor-promoting pathway under specific scenarios, one of which is the inactivation of SMAD4 [65]. Here, SMAD4 is linked to neoplasm.